Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
129.16
-0.02 (-0.02%)
At close: Jun 5, 2026, 4:00 PM EDT
128.53
-0.63 (-0.49%)
After-hours: Jun 5, 2026, 7:56 PM EDT
Gilead Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7,628 | 7,564 | 9,991 | 6,085 | 5,412 | 5,338 |
Short-Term Investments | 15 | 68 | - | 1,179 | 973 | 1,182 |
Cash & Short-Term Investments | 7,643 | 7,632 | 9,991 | 7,264 | 6,385 | 6,520 |
Cash Growth | -3.57% | -23.61% | 37.54% | 13.77% | -2.07% | -11.99% |
Accounts Receivable | 4,741 | 4,913 | 4,420 | 4,660 | 4,777 | 4,493 |
Inventory | 1,914 | 1,774 | 1,710 | 1,787 | 1,507 | 1,618 |
Other Current Assets | 4,342 | 4,024 | 3,052 | 2,374 | 1,774 | 2,141 |
Total Current Assets | 18,641 | 18,342 | 19,173 | 16,085 | 14,443 | 14,772 |
Net Property, Plant & Equipment | 5,638 | 5,606 | 5,414 | 5,317 | 5,475 | 5,121 |
Other Intangible Assets | 16,382 | 16,978 | 19,948 | 26,454 | 28,894 | 33,455 |
Goodwill | 8,314 | 8,314 | 8,314 | 8,314 | 8,314 | 8,332 |
Long-Term Investments | 983 | 2,974 | - | 1,163 | 1,245 | 1,309 |
Other Long-Term Assets | 6,321 | 6,809 | 6,147 | 4,792 | 4,800 | 4,963 |
Total Assets | 56,278 | 59,023 | 58,995 | 62,125 | 63,171 | 67,952 |
Accounts Payable | 645 | 715 | 833 | 550 | 905 | 705 |
Accrued Expenses | 4,118 | 4,337 | 3,892 | 3,802 | 3,479 | 3,244 |
Current Portion of Long-Term Debt | 1,313 | 2,807 | 1,815 | 1,798 | 2,273 | 1,516 |
Other Current Liabilities | 3,399 | 3,953 | 5,464 | 5,130 | 4,580 | 6,145 |
Total Current Liabilities | 9,476 | 11,813 | 12,004 | 11,280 | 11,237 | 11,610 |
Long-Term Debt | 20,861 | 22,129 | 24,896 | 23,189 | 22,957 | 25,179 |
Other Long-Term Liabilities | 2,510 | 2,463 | 2,849 | 4,907 | 7,768 | 10,099 |
Total Long-Term Liabilities | 23,371 | 24,592 | 27,745 | 28,096 | 30,725 | 35,278 |
Total Liabilities | 32,847 | 36,405 | 39,749 | 39,376 | 41,962 | 46,888 |
Common Stock | 1 | 1 | 1 | 1 | 1 | 1 |
Additional Paid-in Capital | 9,305 | 8,932 | 7,700 | 6,500 | 5,550 | 4,661 |
Accumulated Other Comprehensive Income | 78 | 39 | 132 | 28 | 2 | 83 |
Retained Earnings | 14,131 | 13,730 | 11,497 | 16,304 | 15,687 | 16,324 |
Total Common Shareholders' Equity | 23,515 | 22,703 | 19,330 | 22,833 | 21,240 | 21,069 |
Minority Interest | -84 | -84 | -84 | -84 | -31 | -5 |
Shareholders' Equity | 23,431 | 22,618 | 19,246 | 22,749 | 21,209 | 21,064 |
Total Liabilities & Equity | 56,278 | 59,023 | 58,995 | 62,125 | 63,171 | 67,952 |
Total Debt | 22,174 | 24,936 | 26,711 | 24,987 | 25,230 | 26,695 |
Net Cash (Debt) | -14,531 | -17,304 | -16,720 | -17,723 | -18,845 | -20,175 |
Net Cash Per Share | -11.59 | -13.79 | -13.32 | -14.09 | -14.93 | -15.99 |
Book Value | 23,515 | 22,703 | 19,330 | 22,833 | 21,240 | 21,069 |
Book Value Per Share | 18.75 | 18.09 | 15.40 | 18.15 | 16.83 | 16.69 |
Tangible Book Value | -1,181 | -2,589 | -8,932 | -11,935 | -15,968 | -20,718 |
Tangible Book Value Per Share | -0.94 | -2.06 | -7.12 | -9.49 | -12.65 | -16.42 |